Razvi Salman, Shakoor Abdul, Vanderpump Mark, Weaver Jolanta U, Pearce Simon H S
Department of Endocrinology, Queen Elizabeth Hospital, Gateshead, NE9 6SX, United Kingdom.
J Clin Endocrinol Metab. 2008 Aug;93(8):2998-3007. doi: 10.1210/jc.2008-0167. Epub 2008 May 27.
Subclinical hypothyroidism (SCH) is a common condition that has been associated with ischemic heart disease (IHD) in some, but not all, studies. This may be due to differences in study design and the characteristics of participants.
Our objective was to investigate whether age and gender influence IHD prevalence, incidence, and mortality in people with SCH.
Computerized (PubMed, EMBASE, and Cochrane Library) and manual searches of the literature to May 2007, published in English, were performed.
Epidemiological studies that quantified thyroid status and IHD events in adults were performed.
Two authors independently reviewed articles and abstracted data. Results were compared across two groups based on the minimum age of participants studied (younger than 65 yr and 65 yr or older).
There were 15 studies included for analysis with 2,531 SCH participants and 26,491 euthyroid individuals. IHD incidence and prevalence were higher in SCH subjects compared with euthyroid participants from studies including those younger than 65 yr, but not studies of subjects aged older than 65 yr [odds ratio (95% confidence interval)]: 1.57 (1.19-2.06) vs. 1.01 (0.87-1.18) and 1.68 (1.27-2.23) vs. 1.02 (0.85-1.22), respectively. Cardiovascular/all-cause mortality was also elevated in participants from the younger than 65-yr studies, but not from the studies of older people: odds ratio 1.37 (1.04-1.79) vs. 0.85 (0.56-1.29). Prevalent IHD was higher in SCH participants of both genders, although this was statistically significant only in women.
SCH is associated with increased IHD (both prevalence and incidence) and cardiovascular mortality only in subjects from younger populations. These data suggest that increased vascular risk may only be present in younger individuals with SCH.
亚临床甲状腺功能减退(SCH)是一种常见病症,在一些但并非所有研究中,它都与缺血性心脏病(IHD)相关。这可能是由于研究设计和参与者特征的差异所致。
我们的目的是研究年龄和性别是否会影响SCH患者的IHD患病率、发病率和死亡率。
对截至2007年5月以英文发表的文献进行了计算机检索(PubMed、EMBASE和Cochrane图书馆)以及手工检索。
开展了对成年人甲状腺状态和IHD事件进行量化的流行病学研究。
两位作者独立审阅文章并提取数据。根据所研究参与者的最低年龄(小于65岁和65岁及以上)将结果在两组间进行比较。
纳入15项研究进行分析,共有2531名SCH参与者和26491名甲状腺功能正常个体。在纳入年龄小于65岁参与者的研究中,SCH患者的IHD发病率和患病率高于甲状腺功能正常的参与者,但在年龄大于65岁参与者的研究中并非如此[比值比(95%置信区间)]:分别为1.57(1.19 - 2.06)对1.01(0.87 - 1.18)以及1.68(1.27 - 2.23)对1.02(0.85 - 1.22)。年龄小于65岁参与者研究中的心血管/全因死亡率也有所升高,但年龄较大者研究中的死亡率未升高:比值比为1.37(1.04 - 1.79)对0.85(0.56 - 1.29)。两性的SCH参与者中IHD患病率均较高,尽管仅在女性中具有统计学意义。
仅在较年轻人群的SCH患者中,SCH与IHD(患病率和发病率)增加以及心血管死亡率增加相关。这些数据表明,血管风险增加可能仅存在于较年轻的SCH个体中。